nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—TNNC1—Striated Muscle Contraction—TPM4—osteoporosis	0.056	0.154	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM4—osteoporosis	0.0476	0.131	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TPM4—osteoporosis	0.0376	0.103	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—ACTG1—osteoporosis	0.028	0.0771	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TLN1—osteoporosis	0.0225	0.0617	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—VCL—osteoporosis	0.0221	0.0609	CbGpPWpGaD
Levosimendan—Myocardial ischaemia—Ibandronate—osteoporosis	0.0176	0.0277	CcSEcCtD
Levosimendan—Myocardial ischaemia—Estradiol—osteoporosis	0.00973	0.0153	CcSEcCtD
Levosimendan—Hypotension—Calcium Acetate—osteoporosis	0.00868	0.0136	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Estradiol—osteoporosis	0.00866	0.0136	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—PTH1R—osteoporosis	0.0086	0.0236	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—CALCR—osteoporosis	0.0086	0.0236	CbGpPWpGaD
Levosimendan—Atrial fibrillation—Pamidronate—osteoporosis	0.00851	0.0134	CcSEcCtD
Levosimendan—Cardiac failure—Pamidronate—osteoporosis	0.00826	0.013	CcSEcCtD
Levosimendan—Constipation—Calcium Acetate—osteoporosis	0.00794	0.0125	CcSEcCtD
Levosimendan—Atrial fibrillation—Zoledronate—osteoporosis	0.00777	0.0122	CcSEcCtD
Levosimendan—Hypokalaemia—Pamidronate—osteoporosis	0.00734	0.0115	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00711	0.0195	CbGpPWpGaD
Levosimendan—Constipation—Ergocalciferol—osteoporosis	0.00702	0.011	CcSEcCtD
Levosimendan—Cardiac disorder—Estropipate—osteoporosis	0.00689	0.0108	CcSEcCtD
Levosimendan—Angiopathy—Estropipate—osteoporosis	0.00674	0.0106	CcSEcCtD
Levosimendan—Hypokalaemia—Zoledronate—osteoporosis	0.0067	0.0105	CcSEcCtD
Levosimendan—Cardiac disorder—Raloxifene—osteoporosis	0.00668	0.0105	CcSEcCtD
Levosimendan—Cardiac disorder—Ibandronate—osteoporosis	0.00661	0.0104	CcSEcCtD
Levosimendan—Angiopathy—Raloxifene—osteoporosis	0.00653	0.0103	CcSEcCtD
Levosimendan—Mental disorder—Estropipate—osteoporosis	0.00651	0.0102	CcSEcCtD
Levosimendan—Malnutrition—Estropipate—osteoporosis	0.00646	0.0102	CcSEcCtD
Levosimendan—Angiopathy—Ibandronate—osteoporosis	0.00646	0.0102	CcSEcCtD
Levosimendan—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.00645	0.0101	CcSEcCtD
Levosimendan—Diarrhoea—Calcium Acetate—osteoporosis	0.00636	0.00999	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—IRS1—osteoporosis	0.00633	0.0174	CbGpPWpGaD
Levosimendan—Mental disorder—Ibandronate—osteoporosis	0.00624	0.0098	CcSEcCtD
Levosimendan—Malnutrition—Ibandronate—osteoporosis	0.0062	0.00974	CcSEcCtD
Levosimendan—Dizziness—Calcium Acetate—osteoporosis	0.00614	0.00965	CcSEcCtD
Levosimendan—Vomiting—Calcium Acetate—osteoporosis	0.00591	0.00928	CcSEcCtD
Levosimendan—KCNJ11—Regulation of insulin secretion—RAP1A—osteoporosis	0.00577	0.0159	CbGpPWpGaD
Levosimendan—Nausea—Calcium Acetate—osteoporosis	0.00552	0.00867	CcSEcCtD
Levosimendan—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00546	0.00858	CcSEcCtD
Levosimendan—Cardiac disorder—Risedronate—osteoporosis	0.00545	0.00856	CcSEcCtD
Levosimendan—Angiopathy—Risedronate—osteoporosis	0.00532	0.00837	CcSEcCtD
Levosimendan—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00527	0.00829	CcSEcCtD
Levosimendan—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00524	0.00823	CcSEcCtD
Levosimendan—Constipation—Etidronic acid—osteoporosis	0.00521	0.0082	CcSEcCtD
Levosimendan—Cardiac disorder—Pamidronate—osteoporosis	0.00518	0.00814	CcSEcCtD
Levosimendan—Nervous system disorder—Estropipate—osteoporosis	0.00517	0.00813	CcSEcCtD
Levosimendan—Mental disorder—Risedronate—osteoporosis	0.00514	0.00808	CcSEcCtD
Levosimendan—Malnutrition—Risedronate—osteoporosis	0.00511	0.00803	CcSEcCtD
Levosimendan—Angiopathy—Pamidronate—osteoporosis	0.00506	0.00795	CcSEcCtD
Levosimendan—Nervous system disorder—Raloxifene—osteoporosis	0.00501	0.00788	CcSEcCtD
Levosimendan—Nervous system disorder—Ibandronate—osteoporosis	0.00496	0.0078	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.00493	0.0135	CbGpPWpGaD
Levosimendan—Nausea—Ergocalciferol—osteoporosis	0.00487	0.00766	CcSEcCtD
Levosimendan—Malnutrition—Pamidronate—osteoporosis	0.00486	0.00763	CcSEcCtD
Levosimendan—Insomnia—Estropipate—osteoporosis	0.00477	0.0075	CcSEcCtD
Levosimendan—Cardiac disorder—Zoledronate—osteoporosis	0.00473	0.00743	CcSEcCtD
Levosimendan—Angiopathy—Zoledronate—osteoporosis	0.00462	0.00727	CcSEcCtD
Levosimendan—Insomnia—Raloxifene—osteoporosis	0.00462	0.00726	CcSEcCtD
Levosimendan—Insomnia—Ibandronate—osteoporosis	0.00458	0.00719	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Estropipate—osteoporosis	0.00455	0.00716	CcSEcCtD
Levosimendan—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00455	0.00716	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—RAP1A—osteoporosis	0.00453	0.0125	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—PTH—osteoporosis	0.00452	0.0124	CbGpPWpGaD
Levosimendan—Constipation—Estropipate—osteoporosis	0.00451	0.00709	CcSEcCtD
Levosimendan—Insomnia—Calcitriol—osteoporosis	0.00448	0.00704	CcSEcCtD
Levosimendan—Mental disorder—Zoledronate—osteoporosis	0.00446	0.00702	CcSEcCtD
Levosimendan—Angiopathy—Conjugated Estrogens—osteoporosis	0.00445	0.007	CcSEcCtD
Levosimendan—Constipation—Alendronate—osteoporosis	0.00444	0.00698	CcSEcCtD
Levosimendan—Malnutrition—Zoledronate—osteoporosis	0.00444	0.00697	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00441	0.00693	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00437	0.00686	CcSEcCtD
Levosimendan—Constipation—Ibandronate—osteoporosis	0.00433	0.0068	CcSEcCtD
Levosimendan—Mental disorder—Conjugated Estrogens—osteoporosis	0.0043	0.00676	CcSEcCtD
Levosimendan—Malnutrition—Conjugated Estrogens—osteoporosis	0.00427	0.00671	CcSEcCtD
Levosimendan—Constipation—Calcitriol—osteoporosis	0.00424	0.00666	CcSEcCtD
Levosimendan—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00419	0.00659	CcSEcCtD
Levosimendan—Diarrhoea—Etidronic acid—osteoporosis	0.00417	0.00656	CcSEcCtD
Levosimendan—Nervous system disorder—Risedronate—osteoporosis	0.00409	0.00643	CcSEcCtD
Levosimendan—Nervous system disorder—Pamidronate—osteoporosis	0.00389	0.00611	CcSEcCtD
Levosimendan—Vomiting—Etidronic acid—osteoporosis	0.00388	0.00609	CcSEcCtD
Levosimendan—Tachycardia—Pamidronate—osteoporosis	0.00387	0.00608	CcSEcCtD
Levosimendan—Headache—Etidronic acid—osteoporosis	0.00382	0.006	CcSEcCtD
Levosimendan—Insomnia—Risedronate—osteoporosis	0.00377	0.00593	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—PTHLH—osteoporosis	0.00374	0.0103	CbGpPWpGaD
Levosimendan—Hypotension—Pamidronate—osteoporosis	0.0037	0.00582	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00369	0.0058	CcSEcCtD
Levosimendan—Constipation—Ethinyl Estradiol—osteoporosis	0.00366	0.00575	CcSEcCtD
Levosimendan—Cardiac disorder—Estradiol—osteoporosis	0.00364	0.00573	CcSEcCtD
Levosimendan—Nausea—Etidronic acid—osteoporosis	0.00362	0.00569	CcSEcCtD
Levosimendan—Diarrhoea—Estropipate—osteoporosis	0.00361	0.00567	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Risedronate—osteoporosis	0.0036	0.00566	CcSEcCtD
Levosimendan—Insomnia—Pamidronate—osteoporosis	0.00358	0.00563	CcSEcCtD
Levosimendan—Constipation—Risedronate—osteoporosis	0.00357	0.0056	CcSEcCtD
Levosimendan—Angiopathy—Estradiol—osteoporosis	0.00356	0.0056	CcSEcCtD
Levosimendan—Diarrhoea—Alendronate—osteoporosis	0.00356	0.00559	CcSEcCtD
Levosimendan—Nervous system disorder—Zoledronate—osteoporosis	0.00355	0.00558	CcSEcCtD
Levosimendan—Tachycardia—Zoledronate—osteoporosis	0.00353	0.00555	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—WDR1—osteoporosis	0.00353	0.00971	CbGpPWpGaD
Levosimendan—Diarrhoea—Raloxifene—osteoporosis	0.0035	0.0055	CcSEcCtD
Levosimendan—Dizziness—Estropipate—osteoporosis	0.00349	0.00548	CcSEcCtD
Levosimendan—Diarrhoea—Ibandronate—osteoporosis	0.00346	0.00544	CcSEcCtD
Levosimendan—Mental disorder—Estradiol—osteoporosis	0.00344	0.00541	CcSEcCtD
Levosimendan—Dizziness—Alendronate—osteoporosis	0.00344	0.0054	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00342	0.00538	CcSEcCtD
Levosimendan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00342	0.00537	CcSEcCtD
Levosimendan—Malnutrition—Estradiol—osteoporosis	0.00342	0.00537	CcSEcCtD
Levosimendan—Tachycardia—Conjugated Estrogens—osteoporosis	0.0034	0.00535	CcSEcCtD
Levosimendan—Constipation—Pamidronate—osteoporosis	0.00339	0.00533	CcSEcCtD
Levosimendan—Diarrhoea—Calcitriol—osteoporosis	0.00339	0.00533	CcSEcCtD
Levosimendan—Hypotension—Zoledronate—osteoporosis	0.00338	0.00532	CcSEcCtD
Levosimendan—Dizziness—Raloxifene—osteoporosis	0.00338	0.00531	CcSEcCtD
Levosimendan—Vomiting—Estropipate—osteoporosis	0.00335	0.00527	CcSEcCtD
Levosimendan—Dizziness—Ibandronate—osteoporosis	0.00335	0.00526	CcSEcCtD
Levosimendan—Headache—Estropipate—osteoporosis	0.00331	0.00519	CcSEcCtD
Levosimendan—Vomiting—Alendronate—osteoporosis	0.0033	0.00519	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—CALCA—osteoporosis	0.0033	0.00906	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—osteoporosis	0.00328	0.00903	CbGpPWpGaD
Levosimendan—Insomnia—Zoledronate—osteoporosis	0.00327	0.00515	CcSEcCtD
Levosimendan—Hypotension—Conjugated Estrogens—osteoporosis	0.00326	0.00512	CcSEcCtD
Levosimendan—Headache—Alendronate—osteoporosis	0.00326	0.00512	CcSEcCtD
Levosimendan—Vomiting—Raloxifene—osteoporosis	0.00325	0.00511	CcSEcCtD
Levosimendan—Vomiting—Ibandronate—osteoporosis	0.00322	0.00506	CcSEcCtD
Levosimendan—Headache—Raloxifene—osteoporosis	0.0032	0.00503	CcSEcCtD
Levosimendan—Headache—Ibandronate—osteoporosis	0.00317	0.00498	CcSEcCtD
Levosimendan—Insomnia—Conjugated Estrogens—osteoporosis	0.00315	0.00496	CcSEcCtD
Levosimendan—Vomiting—Calcitriol—osteoporosis	0.00315	0.00495	CcSEcCtD
Levosimendan—Nausea—Estropipate—osteoporosis	0.00313	0.00493	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00313	0.00491	CcSEcCtD
Levosimendan—Headache—Calcitriol—osteoporosis	0.0031	0.00488	CcSEcCtD
Levosimendan—Constipation—Zoledronate—osteoporosis	0.0031	0.00487	CcSEcCtD
Levosimendan—Nausea—Alendronate—osteoporosis	0.00309	0.00485	CcSEcCtD
Levosimendan—KCNJ11—Regulation of insulin secretion—ADCY5—osteoporosis	0.00304	0.00837	CbGpPWpGaD
Levosimendan—Nausea—Raloxifene—osteoporosis	0.00304	0.00477	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00301	0.00473	CcSEcCtD
Levosimendan—Nausea—Ibandronate—osteoporosis	0.00301	0.00472	CcSEcCtD
Levosimendan—Constipation—Conjugated Estrogens—osteoporosis	0.00298	0.00469	CcSEcCtD
Levosimendan—Nausea—Calcitriol—osteoporosis	0.00294	0.00462	CcSEcCtD
Levosimendan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00293	0.0046	CcSEcCtD
Levosimendan—Diarrhoea—Risedronate—osteoporosis	0.00285	0.00448	CcSEcCtD
Levosimendan—Dizziness—Ethinyl Estradiol—osteoporosis	0.00283	0.00444	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—CAP1—osteoporosis	0.00279	0.00768	CbGpPWpGaD
Levosimendan—Dizziness—Risedronate—osteoporosis	0.00276	0.00433	CcSEcCtD
Levosimendan—Nervous system disorder—Estradiol—osteoporosis	0.00274	0.0043	CcSEcCtD
Levosimendan—Tachycardia—Estradiol—osteoporosis	0.00272	0.00428	CcSEcCtD
Levosimendan—Vomiting—Ethinyl Estradiol—osteoporosis	0.00272	0.00427	CcSEcCtD
Levosimendan—Diarrhoea—Pamidronate—osteoporosis	0.00271	0.00426	CcSEcCtD
Levosimendan—Headache—Ethinyl Estradiol—osteoporosis	0.00268	0.00421	CcSEcCtD
Levosimendan—Vomiting—Risedronate—osteoporosis	0.00265	0.00417	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00262	0.00721	CbGpPWpGaD
Levosimendan—Dizziness—Pamidronate—osteoporosis	0.00262	0.00412	CcSEcCtD
Levosimendan—Headache—Risedronate—osteoporosis	0.00261	0.0041	CcSEcCtD
Levosimendan—Nausea—Ethinyl Estradiol—osteoporosis	0.00254	0.00399	CcSEcCtD
Levosimendan—Insomnia—Estradiol—osteoporosis	0.00252	0.00397	CcSEcCtD
Levosimendan—Vomiting—Pamidronate—osteoporosis	0.00252	0.00396	CcSEcCtD
Levosimendan—Headache—Pamidronate—osteoporosis	0.00248	0.0039	CcSEcCtD
Levosimendan—Diarrhoea—Zoledronate—osteoporosis	0.00248	0.00389	CcSEcCtD
Levosimendan—Nausea—Risedronate—osteoporosis	0.00248	0.00389	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Estradiol—osteoporosis	0.00241	0.00379	CcSEcCtD
Levosimendan—Dizziness—Zoledronate—osteoporosis	0.00239	0.00376	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—ADCY5—osteoporosis	0.00239	0.00658	CbGpPWpGaD
Levosimendan—Constipation—Estradiol—osteoporosis	0.00239	0.00375	CcSEcCtD
Levosimendan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00239	0.00375	CcSEcCtD
Levosimendan—Nausea—Pamidronate—osteoporosis	0.00235	0.0037	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—ADCY5—osteoporosis	0.00234	0.00645	CbGpPWpGaD
Levosimendan—Dizziness—Conjugated Estrogens—osteoporosis	0.00231	0.00362	CcSEcCtD
Levosimendan—Vomiting—Zoledronate—osteoporosis	0.0023	0.00362	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—ADCY5—osteoporosis	0.0023	0.00631	CbGpPWpGaD
Levosimendan—Headache—Zoledronate—osteoporosis	0.00227	0.00356	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—MGLL—osteoporosis	0.00222	0.0061	CbGpPWpGaD
Levosimendan—Vomiting—Conjugated Estrogens—osteoporosis	0.00222	0.00348	CcSEcCtD
Levosimendan—Headache—Conjugated Estrogens—osteoporosis	0.00218	0.00343	CcSEcCtD
Levosimendan—Nausea—Zoledronate—osteoporosis	0.00215	0.00338	CcSEcCtD
Levosimendan—Nausea—Conjugated Estrogens—osteoporosis	0.00207	0.00325	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—ANXA2—osteoporosis	0.00203	0.00558	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLEK—osteoporosis	0.00203	0.00558	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00199	0.00548	CbGpPWpGaD
Levosimendan—Diarrhoea—Estradiol—osteoporosis	0.00191	0.003	CcSEcCtD
Levosimendan—Dizziness—Estradiol—osteoporosis	0.00184	0.0029	CcSEcCtD
Levosimendan—Vomiting—Estradiol—osteoporosis	0.00177	0.00279	CcSEcCtD
Levosimendan—PDE3A—GPCR downstream signaling—CALCR—osteoporosis	0.00176	0.00485	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTH1R—osteoporosis	0.00176	0.00485	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TLN1—osteoporosis	0.00175	0.00481	CbGpPWpGaD
Levosimendan—Headache—Estradiol—osteoporosis	0.00175	0.00275	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—VCL—osteoporosis	0.00173	0.00474	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—POMC—osteoporosis	0.00172	0.00474	CbGpPWpGaD
Levosimendan—Nausea—Estradiol—osteoporosis	0.00166	0.0026	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—CALCR—osteoporosis	0.0016	0.00441	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTH1R—osteoporosis	0.0016	0.00441	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00145	0.00398	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAP1A—osteoporosis	0.00144	0.00396	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—MGLL—osteoporosis	0.0014	0.00385	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FGA—osteoporosis	0.00131	0.00359	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MGLL—osteoporosis	0.00127	0.0035	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FGB—osteoporosis	0.00119	0.00327	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—osteoporosis	0.00117	0.00321	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FDPS—osteoporosis	0.00111	0.00305	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PKM—osteoporosis	0.00111	0.00305	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—ADCY5—osteoporosis	0.00109	0.00299	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PGLS—osteoporosis	0.00105	0.00289	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPD2—osteoporosis	0.00105	0.00289	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SOST—osteoporosis	0.00105	0.00288	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ATIC—osteoporosis	0.000963	0.00265	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PNP—osteoporosis	0.000963	0.00265	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTH1R—osteoporosis	0.000947	0.0026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALCR—osteoporosis	0.000947	0.0026	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTH—osteoporosis	0.000927	0.00255	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CNR2—osteoporosis	0.000903	0.00248	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTH—osteoporosis	0.000842	0.00231	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CNR2—osteoporosis	0.00082	0.00226	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA2—osteoporosis	0.000819	0.00225	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—OXCT1—osteoporosis	0.000819	0.00225	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MGLL—osteoporosis	0.000798	0.00219	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—WNT1—osteoporosis	0.000771	0.00212	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTHLH—osteoporosis	0.000768	0.00211	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MGLL—osteoporosis	0.000752	0.00207	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LRP5—osteoporosis	0.000734	0.00202	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LRP6—osteoporosis	0.000702	0.00193	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTHLH—osteoporosis	0.000698	0.00192	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—IDH2—osteoporosis	0.000678	0.00186	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CALCA—osteoporosis	0.000676	0.00186	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP27A1—osteoporosis	0.000638	0.00175	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACP5—osteoporosis	0.00062	0.00171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CALCA—osteoporosis	0.000614	0.00169	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TLN1—osteoporosis	0.000593	0.00163	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TPI1—osteoporosis	0.000577	0.00159	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—P4HB—osteoporosis	0.000542	0.00149	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—osteoporosis	0.000539	0.00148	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GAPDH—osteoporosis	0.000532	0.00146	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RAP1A—osteoporosis	0.000518	0.00143	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—P4HB—osteoporosis	0.000511	0.00141	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTH—osteoporosis	0.000497	0.00137	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAP1A—osteoporosis	0.000489	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CNR2—osteoporosis	0.000485	0.00133	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADCY5—osteoporosis	0.000481	0.00132	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFATC1—osteoporosis	0.000477	0.00131	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DKK1—osteoporosis	0.000473	0.0013	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WNT1—osteoporosis	0.000456	0.00125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGA—osteoporosis	0.000443	0.00122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADCY5—osteoporosis	0.000437	0.0012	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO1—osteoporosis	0.000419	0.00115	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSMA5—osteoporosis	0.000413	0.00114	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSMA2—osteoporosis	0.000413	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BMP2—osteoporosis	0.000412	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTHLH—osteoporosis	0.000412	0.00113	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGB—osteoporosis	0.000403	0.00111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSMA2—osteoporosis	0.000389	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSMA5—osteoporosis	0.000389	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALCA—osteoporosis	0.000363	0.000997	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—POMC—osteoporosis	0.000354	0.000973	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP19A1—osteoporosis	0.000335	0.000921	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KL—osteoporosis	0.000329	0.000906	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—osteoporosis	0.000323	0.000888	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—POMC—osteoporosis	0.000321	0.000883	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6R—osteoporosis	0.000313	0.000862	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADCY5—osteoporosis	0.000274	0.000752	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX1—osteoporosis	0.000273	0.00075	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADCY5—osteoporosis	0.000258	0.000709	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—osteoporosis	0.000252	0.000692	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPP1—osteoporosis	0.00025	0.000686	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS2—osteoporosis	0.000226	0.000621	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—osteoporosis	0.000221	0.000607	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ESR1—osteoporosis	0.000211	0.00058	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—POMC—osteoporosis	0.000201	0.000553	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS1—osteoporosis	0.000197	0.000542	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—POMC—osteoporosis	0.00019	0.000522	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6R—osteoporosis	0.000185	0.000509	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—osteoporosis	0.000183	0.000502	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—osteoporosis	0.00014	0.000384	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—osteoporosis	0.00011	0.000302	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—osteoporosis	0.000109	0.000301	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—osteoporosis	8.25e-05	0.000227	CbGpPWpGaD
